Informations sur le produit
- 10058-F4
- 10058F4
- (E)-5-(4-Ethylbenzylidene)-2-thioxothiazolidin-4-one
- (5E)-5-(4-Ethylbenzylidene)-2-thioxo-1,3-thiazolidin-4-one
- (5Z)-5-(4-ethylbenzylidene)-2-thioxo-1,3-thiazolidin-4-one
- 4(5H)-thiazolone, 5-[(4-ethylphenyl)methylene]-2-mercapto-, (5E)-
- 4(5H)-thiazolone, 5-[(4-ethylphenyl)methylene]-2-mercapto-, (5Z)-
- 4-Thiazolidinone, 5-[(4-ethylphenyl)methylene]-2-thioxo-
- 4-thiazolidinone, 5-[(4-ethylphenyl)methylene]-2-thioxo-, (5E)-
Applications 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone is a c-Myc inhibitor that specifically inhibits c-Myc-Max interaction, function and prevents transactivation of c-Myc target gene expression. The use of 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone is a potential antileukamic approach due to its affects on multiple cellular activities in acute myeloid leukemia (AML).
References Yin, X., et. al.: Oncogene, 22, 6151 (2003); Huang, M., et. al.: Exp. Hematol, 34, 1480 (2006)